Show Notes
In this episode of Don't Call Me Resilient, we are joined by fat and disability studies professor Fady Shanouda, who examines anti-fat bias in medicine. As the use of Ozempic, a drug for diabetes, slams into the mainstream as a weight-loss method, will the drug’s use impact our concept of fatness? And how does fatness intersect with race and class?
More from Don’t Call Me Resilient
It’s hard not to categorize our present global moment as a crisis. And just when we think things can't get worse — they do.
By now… you probably know what an “influencer” is – individuals with large, highly engaged social media followings who have the power to sway beliefs and purchasing decisions.
Don't Call Me Resilient is coming back to your podcast feed this month with a whole new series!
You may have noticed, Don’t Call Me Resilient hasn’t been in your feed lately.